Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
This biopharma firm, focused on therapies for autoimmune diseases, reported a recent insider buy amid a year of strong share performance.
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
Overview
Kevin Tang, Chief Executive Officer of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), reported the purchase of 814,606 common shares across multiple transactions between May 29, 2026, and June 2, 2026, according to a SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($15.29).
Details
* 1-year performance calculated using June 5, 2026, as the reference date.
Source
Originally published at www.fool.com.
Related Articles
- 51% of U.S. adults say the American Dream is out of reach for most people right now: CNBC survey
- A massive 16% market swing just rocked South Korea over 24 hours. The retail ‘ants’ holding the wheel are driving dangerously.
- I’m 60, retired with $3 million. My fiancée, 55, has $1 million but plans to work for the next 10 years. Are we compatible?
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
